Terns Pharmaceuticals, Inc. short interest in 2025
In 2025, Terns Pharmaceuticals, Inc.'s disclosed short interest ran from 8.99% of shares outstanding on 15 Jan 2025 to 17.15% on 31 Dec 2025, a change of +8.16 percentage points. The year's high was 17.15% on 31 Dec 2025 and its low 6.20% on 30 Apr 2025, averaging 8.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.07 days on 30 May 2025. Full history: Terns Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 8.99% (15 Jan 2025)
- End of year
- 17.15% (31 Dec 2025)
- Change
- +8.16 pp
- High
- 17.15% (31 Dec 2025)
- Low
- 6.20% (30 Apr 2025)
- Average
- 8.73%
- Highest days to cover
- 9.07 (30 May 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 8.99% | 4.82 | |
| 31 Jan 2025 | 7.60% | 3.06 | |
| 14 Feb 2025 | 6.96% | 4.02 | |
| 28 Feb 2025 | 7.29% | 5.81 | |
| 14 Mar 2025 | 6.81% | 5.75 | |
| 31 Mar 2025 | 6.60% | 6.73 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 6.39% | 3.57 | |
| 30 Apr 2025 | 6.20% | 5.09 | |
| 15 May 2025 | 6.25% | 6.13 | 10-Q filed, results (8-K) |
| 30 May 2025 | 6.23% | 9.07 | |
| 13 Jun 2025 | 6.81% | 6.00 | |
| 30 Jun 2025 | 7.00% | 6.96 | |
| 15 Jul 2025 | 6.89% | 6.69 | |
| 31 Jul 2025 | 7.71% | 6.68 | |
| 15 Aug 2025 | 8.14% | 5.69 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 8.98% | 7.55 | |
| 15 Sep 2025 | 9.49% | 6.72 | |
| 30 Sep 2025 | 9.40% | 8.49 | |
| 15 Oct 2025 | 11.84% | 7.89 | |
| 31 Oct 2025 | 12.22% | 5.53 | |
| 14 Nov 2025 | 10.56% | 1.30 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 9.75% | 2.33 | |
| 15 Dec 2025 | 14.17% | 2.00 | |
| 31 Dec 2025 | 17.15% | 6.07 |
See also: Terns Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.